Your browser is no longer supported. Please, upgrade your browser.
RTRX Retrophin, Inc. daily Stock Chart
Retrophin, Inc.
Index- P/E- EPS (ttm)-1.50 Insider Own0.70% Shs Outstand39.68M Perf Week-9.79%
Market Cap902.72M Forward P/E- EPS next Y-1.50 Insider Trans-0.71% Shs Float29.78M Perf Month1.84%
Income-58.70M PEG- EPS next Q-0.47 Inst Own- Short Float10.95% Perf Quarter2.76%
Sales154.90M P/S5.83 EPS this Y-17.00% Inst Trans-1.52% Short Ratio10.18 Perf Half Y0.22%
Book/sh7.30 P/B3.12 EPS next Y41.20% ROA-11.60% Target Price35.67 Perf Year29.78%
Cash/sh7.58 P/C3.00 EPS next 5Y20.00% ROE-20.00% 52W Range15.55 - 26.44 Perf YTD7.97%
Dividend- P/FCF138.88 EPS past 5Y28.80% ROI-16.00% 52W High-13.96% Beta1.00
Dividend %- Quick Ratio3.70 Sales past 5Y- Gross Margin97.70% 52W Low46.30% ATR0.96
Employees173 Current Ratio3.80 Sales Q/Q13.10% Oper. Margin-34.70% RSI (14)32.78 Volatility3.52% 4.19%
OptionableYes Debt/Eq0.15 EPS Q/Q-81.80% Profit Margin-38.60% Rel Volume0.61 Prev Close23.40
ShortableYes LT Debt/Eq0.15 EarningsFeb 27 AMC Payout- Avg Volume320.28K Price22.75
Recom1.50 SMA20-8.45% SMA50-5.20% SMA2001.01% Volume194,412 Change-2.78%
Nov-02-15Initiated JMP Securities Mkt Outperform $30
Jun-04-15Reiterated Deutsche Bank Buy $52 → $55
May-15-15Initiated Avondale Mkt Outperform
Apr-28-15Initiated Deutsche Bank Buy $50
Mar-16-18 06:36PM  Shkreli bragged exam would would show 150 IQ and 'no overt psychological issues.' He was wrong CNBC
07:35AM  Analysis: Positioning to Benefit within Capella Education, Access National, Randgold Resources, Diodes, Silicon Motion Technology, and Retrophin Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Mar-14-18 01:56PM  'Pharma bro' fraudster Martin Shkreli: I want to serve prison in a minimum-security federal camp CNBC
01:05PM  Shkreli asks judge to recommend a high-security federal prison in Pennsylvania American City Business Journals
Mar-09-18 04:12PM  'Pharma Bro' Shkreli sentenced to 7 years for defrauding investors Reuters
03:48PM  'Pharma Bro' Shkreli sentenced to 7 years for defrauding investors Reuters
02:19PM  'Pharma Bro' Shkreli sentenced to seven years for defrauding investors Reuters
02:16PM  'Pharma Bro' Shkreli sentenced to 7 years for defrauding investors Reuters
02:10PM  'Pharma Bro' Martin Shkreli Gets 7 Years In Prison For Securities Fraud Benzinga
01:57PM  Martin Shkreli Sentenced to Seven Years in Prison Bloomberg
01:56PM  'Pharma bro' Martin Shkreli sentenced to 7 years in prison says 'This is my fault' CNBC
Mar-08-18 10:00AM  Martin Shkrelis Journey From Pharma Exec to Inmate #87850-053 Bloomberg
Mar-06-18 12:59PM  Prosecutors ask judge to put 'pharma bro' Martin Shkreli in prison for at least 15 years CNBC
Mar-05-18 04:30PM  Retrophin Announces Appointment of Casey Logan as Vice President of Corporate Development GlobeNewswire
12:49PM  Martin Shkreli must forfeit $7.36 million, turn over stake in ultra-rare Wu-Tang Clan album: Judge CNBC
Feb-28-18 04:30PM  Retrophin to Present at the Barclays Global Healthcare Conference GlobeNewswire +5.21%
03:39PM  'Pharma bro' Martin Shkreli tells judge: 'I was a fool' CNBC
01:57PM  'Kind, caring, generous' Martin Shkreli wants sentence of just 12 to 18 months in prison CNBC
01:08PM  'Pharma bro' Shkreli seeks 12 to 18 month sentence, below guidelines Reuters
Feb-27-18 06:15PM  Retrophin reports 4Q loss Associated Press
04:01PM  Retrophin Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
12:50PM  Retrophin, Inc. to Host Earnings Call ACCESSWIRE
12:43PM  Retrophin Q4 Earnings Preview Benzinga
Feb-26-18 01:13PM  'Pharma bro' Shkreli to be held responsible for $10.4 million in losses: U.S. judge Reuters
01:07PM  Big 'loss' for Martin Shkreli: Judge's ruling means 'pharma bro' could get decade or more in prison CNBC
Feb-23-18 01:28PM  Martin Shkreli sports a jailhouse beard as judge weighs big questions on investors' losses CNBC +6.76%
01:22PM  Shkreli loses bid to toss stock manipulation conviction Reuters
Feb-13-18 04:30PM  Retrophin to Report Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
Feb-01-18 04:30PM  Retrophin to Present at the Leerink Partners 7th Annual Global Healthcare Conference GlobeNewswire
Jan-15-18 08:35AM  Are Options Traders Betting on a Big Move in Retrophin (RTRX) Stock? Zacks
Jan-08-18 07:00AM  Retrophin Provides Corporate Update and 2018 Outlook GlobeNewswire
Jan-05-18 08:00AM  Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU) GlobeNewswire
Dec-28-17 04:30PM  Retrophin to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
12:40AM  [$$] Martin Shkrelis Former Lawyer Convicted of Aiding Fraud Scheme The Wall Street Journal
Dec-27-17 09:18PM  Ex-lawyer for pharma executive Shkreli convicted of aiding fraud scheme Reuters
06:36PM  [$$] Martin Shkreli's Former Lawyer Convicted of Aiding Fraud Scheme The Wall Street Journal
05:52PM  Ex-lawyer for pharma exec Shkreli convicted of aiding fraud scheme Reuters
02:23PM  Shkrelis Ex-Lawyer Convicted of Aiding Him in Fraud Scheme Bloomberg
11:45AM  ETFs with exposure to Retrophin, Inc. : December 27, 2017 Capital Cube
Dec-26-17 08:54AM  Retrophin, Inc. :RTRX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017 Capital Cube
Dec-18-17 08:30AM  Options Traders Expect Huge Moves in Retrophin (RTRX) Stock Zacks
Dec-14-17 11:20AM  Trial of Martin Shkreli's lawyer interrupted by 'serious' claims about government official CNBC
Dec-06-17 07:00AM  A Martin Shkreli Trial Without the Outbursts, Anger or `Trashy' Bloomberg
Nov-30-17 04:30PM  Retrophin to Present at the BMO 2017 Prescriptions for Success Healthcare Conference GlobeNewswire
Nov-09-17 10:44PM  Edited Transcript of RTRX earnings conference call or presentation 7-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
01:35PM  Retrophin, Inc. Value Analysis (NASDAQ:RTRX) : November 9, 2017 Capital Cube
Nov-08-17 01:44PM  Retrophin, Inc. breached its 50 day moving average in a Bullish Manner : RTRX-US : November 8, 2017 Capital Cube -10.78%
Nov-07-17 05:41PM  Retrophin reports 3Q loss Associated Press
04:20PM  Retrophin Reports Third Quarter 2017 Financial Results Marketwired
12:30PM  Retrophin, Inc. to Host Earnings Call ACCESSWIRE
Nov-03-17 06:40PM  Retrophin Reports Additional Positive Data from Open-Label Extension of Phase 2 DUET Study of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis (FSGS) GlobeNewswire
Nov-02-17 04:30PM  Retrophin to Present at the Jefferies 2017 London Healthcare Conference GlobeNewswire
Oct-26-17 08:20AM  Retrophin, Inc. breached its 50 day moving average in a Bearish Manner : RTRX-US : October 26, 2017 Capital Cube
Oct-24-17 04:30PM  Retrophin to Report Third Quarter 2017 Financial Results GlobeNewswire
Oct-20-17 04:06PM  Lawyer charged alongside Martin Shkreli goes on trial Reuters
03:23PM  Shkreli Lawyer, on Trial Himself, Seeks Distance From Shkreli Bloomberg
Oct-17-17 07:23AM  Edited Transcript of RTRX earnings conference call or presentation 1-Mar-17 10:00pm GMT Thomson Reuters StreetEvents
Oct-16-17 07:00AM  Adviser or Accomplice? Spotlight Moves to Shkrelis Ex-Lawyer Bloomberg
Oct-15-17 07:42PM  [$$] Jury Selection to Begin in Trial of Martin Shkrelis Lawyer The Wall Street Journal
07:00AM  [$$] Jury Selection to Begin in Trial of Martin Shkreli's Lawyer The Wall Street Journal
Oct-13-17 04:05PM  Retrophin to Present New Data for Sparsentan at ASN Kidney Week 2017 GlobeNewswire
Oct-05-17 04:30PM  Retrophin Announces Presentation of New Data from Physician-Initiated Treatment with Fosmetpantotenate at the Child Neurology Societys 26th Annual Meeting GlobeNewswire
Oct-02-17 11:05AM  ETFs with exposure to Retrophin, Inc. : October 2, 2017 Capital Cube
Sep-29-17 09:03AM  Retrophin, Inc. :RTRX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-14-17 04:27PM  Martin Shkreli's new jailhouse home is 'not where you want to be': Defense lawyer CNBC
03:01PM  How Hillary Clinton and Martin Shkreli both wanted somebody else's DNA CNBC
Sep-13-17 02:10PM  Shkreli could get locked up Wednesday if bail revoked over bizarre Hillary Clinton hair stunt CNBC
Sep-11-17 04:30PM  Retrophin to Present at September Investor Conferences GlobeNewswire
Sep-08-17 06:34PM  Martin Shkreli seeks to overturn part of his conviction Reuters
Sep-07-17 10:37PM  Prosecutors ask judge to revoke bond of convicted fraudster Martin Shkreli after threats to Clinton CNBC
Sep-05-17 08:00AM  Retrophin Announces Cooperative Research and Development Agreement with NCATS and to Identify Potential Small Molecule Therapeutics for NGLY1 Deficiency GlobeNewswire
Aug-15-17 02:38PM  Pharma bro Martin Shkreli: 'I don't think I'm going to jail' CNBC
Aug-14-17 04:30PM  Retrophin Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Aug-12-17 06:56PM  Edited Transcript of RTRX earnings conference call or presentation 9-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-11-17 09:24AM  Sentencing Is When Martin Shkreli's Antics Will Come Back To Haunt Him Forbes +5.66%
Aug-09-17 05:06PM  Retrophin reports 2Q loss Associated Press
04:01PM  Retrophin Reports Second Quarter 2017 Financial Results GlobeNewswire
01:00PM  Investor Network: Retrophin, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-17 09:31AM  Shkreli's Delight and Crypto Karma Bloomberg
Aug-06-17 01:45PM  Shkreli sentence turns on antics, investor impact of crime Reuters
Aug-04-17 06:55PM  'Pharma bro' Shkreli convicted of fraud in U.S. court, assails 'witch hunt' Reuters
06:22PM  'Pharma bro' Martin Shkreli found guilty of 3 of 8 charges, including securities fraud CNBC
05:28PM  Martin Shkreli livestreams on YouTube after verdict in trial, talks about doing 'God's work' CNBC
05:01PM  Why Pharma Bro Martin Shkreli Is Swaggering Into Jail Bloomberg
03:28PM  'Pharma Bro' Martin Shkreli Reacts to Fraud Conviction Bloomberg Video
03:16PM  Shkreli Convicted of Securities Fraud by U.S. Jury Bloomberg Video
03:09PM  Martin Shkreli Found Guilty On 3 Counts, Including Securities Fraud Benzinga
02:46PM  Martin Shkreli on verdict: This was a witch hunt of epic ... CNBC Videos
02:39PM  'Pharma bro' Martin Shkreli convicted in federal fraud case CNBC
01:45PM  In Martin Shkreli's courtroom, another defendant named 'Martin Shkreli' makes an appearance CNBC
Aug-03-17 02:39PM  Securities experts chime in on Shkreli trial American City Business Journals
Aug-02-17 05:36PM  Shkreli Jury Ends Third Day of Deliberations Without a Verdict Bloomberg
Aug-01-17 06:03PM  Jury in Martin Shkreli trial seeks clarity on 'fraudulent intent' Reuters
05:45PM  Jurors ask about fraud 'intent' at Martin Shkreli trial; 'pharma bro' reads Warren Buffett biography CNBC
Jul-31-17 04:26PM  Pharma Bro Martin Shkreli Awaits Jury Decision in Fraud Case
01:14PM  What if Shkreli isn't convicted? It would be a major embarrassment, attorney says American City Business Journals
09:51AM  Shkreli Jury Begins Deliberations in Brooklyn Fraud Trial Bloomberg
Jul-28-17 05:52PM  Jurors in Martin Shkreli case will begin deliberations Monday CNBC
03:59PM  Martin Shkreli gets smacked down on Twitter (again) after another lewd comment about reporter CNBC
03:52PM  Shkreli Jury to Start Deliberations in Fraud Trial July 31 Bloomberg
Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of patients with peroxisomal disorders; and Thiola, a tiopronin tablet for the treatment of cystinuria. The company's product candidates consist of Fosmetpantotenate, a novel small molecule that is in Phase III clinical trial to treat pantothenate kinase-associated neurodegeneration; Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis; CNSA-001, an orally bioavailable proprietary form of sepiapterin that is in phase I clinical trial for the treatment of phenylketonuria; and Liquid Ursodeoxycholic Acid, a liquid formulation of ursodeoxycholic acid, which is in Phase III clinical trial for the treatment of primary biliary cholangitis. Retrophin, Inc. was founded in 2011 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASELAGE STEVEChief Executive OfficerMar 07Option Exercise6.002781,668221,383Mar 08 09:13 PM
ROTE WILLIAM E.Senior Vice President, R&DFeb 14Sale21.501,03422,23211,156Feb 16 07:39 PM
REED ELIZABETH ESVP, GC & Corporate SecretaryJan 05Sale24.0494222,6469,058Jan 08 07:58 PM
McFarlane Neil F.Chief Operating OfficerAug 16Sale22.501,37831,00513,622Aug 17 08:36 PM